We are live on ! Find out more
FCMC

Founders Capital Management (Connecticut) Portfolio holdings

AUM $670M
1-Year Est. Return 28.54%
This Fund
S&P 500
This Quarter Est. Return
+3.08%
1 Year Est. Return
+28.54%
3 Year Est. Return
+88.87%
5 Year Est. Return
+103.48%
10 Year Est. Return
+356.59%
AUM
$200M
AUM Growth
+$4.71M
Cap. Flow
-$1.03M
Cap. Flow %
-0.51%
Top 10 Hldgs %
52.78%
Holding
56
New
1
Increased
1
Reduced
1
Closed
1

Top Buys

Rank Stock Value
1
UNH icon
UnitedHealth
UNH
+$194K
2
DVA icon
DaVita
DVA
+$34.4K

Top Sells

Rank Stock Value
1
GILD icon
Gilead Sciences
GILD
+$1.21M
2
PG icon
Procter & Gamble
PG
+$51.6K

Sector Composition

Rank Sector Weight
1 Healthcare 21.85%
2 Industrials 18.34%
3 Financials 14.9%
4 Technology 13.51%
5 Consumer Staples 10.8%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BMY icon
51
Bristol-Myers Squibb
BMY
$132B
$230K 0.11%
4,097
– –
DD icon
52
DuPont de Nemours
DD
$19.2B
$206K 0.1%
1,285
– –
UNH icon
53
UnitedHealth
UNH
$370B
$205K 0.1%
+1,108
New +$194K
BHI
54
DELISTED
Baker Hughes
BHI
$203K 0.1%
3,717
– –
EPD icon
55
Enterprise Products Partners
EPD
$81.7B
$191K 0.1%
7,057
– –
GILD icon
56
Gilead Sciences
GILD
$165B
– –
-17,777
Closed -$1.21M
1 2
3

Similar funds

LCM
Lonestar Capital Management San Francisco, California $671M AUM 72.56% 1-Year Est. Return
AGM
Alpine Global Management New York $668M AUM 20.22% 1-Year Est. Return
CHCM
Columbus Hill Capital Management Short Hills, New Jersey $673M AUM 24.63% 1-Year Est. Return
TAP
TSG Advice Partners Columbus, Ohio $667M AUM
CCM
Corsair Capital Management New York $673M AUM 109.99% 1-Year Est. Return
WSCM
Wellington Shields Capital Management New York $666M AUM 45.43% 1-Year Est. Return
GCIA
Gabelli & Co Investment Advisers Rye, New York $674M AUM 64.46% 1-Year Est. Return
BCP
Bain Capital Prairie Boston, Massachusetts $666M AUM

Founders Capital Management (Connecticut)'s Q2 2017 Portfolio in Review

As of Q2 2017, Founders Capital Management (Connecticut) held 56 positions worth $200M, up 2.4% from $196M the previous quarter. Its ten largest holdings account for 53% of the portfolio.

Trading was light in Q2 2017: portfolio turnover was 3.6%. Founders Capital Management (Connecticut) opened 1 new position and exited 1, leaving the 56-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 22% of assets, up from 22% a quarter earlier, followed by Industrials and Financials.

  • Founders Capital Management (Connecticut)'s largest Q2 2017 buy was UnitedHealth: 1,108 shares worth $205K.
  • Founders Capital Management (Connecticut) added most to DaVita in Q2 2017, an estimated $34.4K increase.
  • Founders Capital Management (Connecticut)'s biggest Q2 2017 reduction was Procter & Gamble, cutting an estimated $51.6K.
  • Founders Capital Management (Connecticut) fully exited Gilead Sciences in Q2 2017, selling an estimated $1.21M.
  • Founders Capital Management (Connecticut)'s ten largest holdings make up 53% of its $200M portfolio in Q2 2017.
  • Founders Capital Management (Connecticut) opened 1 new position and closed 1 in Q2 2017.
  • Founders Capital Management (Connecticut)'s portfolio value rose 2.4% quarter-over-quarter to $200M.

Based on Founders Capital Management (Connecticut)'s 13F filing for Q2 2017, filed 20 Jul 2017.